Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2009-09-25 M&A Activity
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
M&A Activity 2009
M&A Activity Classification · 98% confidence The document is titled "Meddelelse om overtagelsestilbud" (Announcement of Takeover Bid) and explicitly states that Kiwi Deposit Holdings A/S has acquired 64.5% of the shares, triggering a mandatory offer obligation according to Danish securities law (værdipapirhandelslovens § 2, stk. 1). It details the offer price (kr. 30.1 cash) and mentions that the detailed terms will follow in a formal takeover bid document which is currently being prepared. This content directly relates to a merger or takeover proposal. Therefore, the appropriate classification is M&A Activity (TAR). The document length is short (1132 chars) and it announces a future, more detailed document, but the core subject matter is the takeover bid itself, making TAR more specific than RPA or RNS.
2009-09-25 English
M&A Activity 2009
M&A Activity
2009-09-25 Danish
M&A Activity 2009
M&A Activity Classification · 98% confidence The document is a formal announcement dated September 21, 2009, detailing the results of a voluntary takeover bid ('frivillige overtagelsestilbud') made by KlimaInvest A/S for shares in Gudme Raaschou Vision A/S. It specifies the offer price, the acceptance rate (1.03%), and the subsequent plan to sell the acquired shares. This content directly relates to a merger or takeover proposal/activity. Based on the definitions, this aligns perfectly with the 'M&A Activity' category (Code: TAR). The document is a specific announcement about a takeover bid, not a general regulatory filing (RNS) or a report itself.
2009-09-21 English
M&A Activity 2009
M&A Activity
2009-09-21 Danish
Major Shareholding Notification 2009
Major Shareholding Notification
2009-09-16 Danish
Major Shareholding Notification 2009
Major Shareholding Notification Classification · 98% confidence The document is titled "Storaktionærmeddelelse" (Major Shareholder Announcement) and explicitly states that Kíwi Deposit Holdings A/S has acquired 64.5% of the shares in Gudme Raaschou Vision A/S, referencing Danish Securities Trading Act § 29. This directly relates to a change in significant share ownership crossing a threshold. The document length is very short (617 chars) and mentions that Form 1 has been submitted to the Financial Supervisory Authority (Finanstilsynet), indicating it is an announcement of a transaction or ownership change rather than the full report itself. This aligns perfectly with the definition for Major Shareholding Notification (MRQ).
2009-09-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.